1. The shape of the docket

Read in aggregate, the federal mass tort system looks enormous and sprawling. Read by where the cases actually sit, it looks like a short list of mega-dockets with a long tail trailing behind them. As of the JPML's May 1, 2026 distribution report, the system held on the order of 199,700 pending actions across roughly 159 active multidistrict litigations, but the distribution is so lopsided that the headline count is almost the least useful number in it.

Dockets carrying 1,000 or more pending actions make up only about an eighth of all active MDLs, yet they hold the overwhelming majority of the cases. The concentration is not a quirk of one big year; it is the structural fact that shapes leadership appointments, settlement leverage, and where the plaintiff bar spends its advertising dollars.

Within that top tier, one docket dominates everything else. Johnson & Johnson's talc litigation alone accounts for roughly a third of all pending federal MDL actions, more than the next several dockets combined, which is why a single bankruptcy ruling in Texas can move the entire system's case count.

2. The growth is inside the mega-dockets

The number of active MDLs is flat to slightly declining, down from roughly 170 in early 2025 to about 159 a year later. What is growing is the size of the dockets that already dominate. Talc is the clearest illustration: the count climbed steeply through mid-2025 and then plateaued near 67,000–68,000, the shape you would expect from a docket whose proposed exit ramp collapsed and whose claims had nowhere to go but back into active litigation.

The opposite shape, near-vertical growth, belongs to Depo-Provera. It is the fastest-growing MDL in the federal system by a wide margin, more than doubling in a single quarter, including a single month in which it added roughly a thousand cases. For anyone tracking where intake advertising and referral volume are flowing right now, this is the cleanest signal on the board.

3. The bellwether turn

For most of the last three years, the mega-dockets generated motion practice, not verdicts. That changed in the first half of 2026. Within roughly six months, the litigation produced the first jury verdict in the social-media docket, the first bellwether result in Bard PowerPort, a reset of the AFFF personal-injury track, and a string of state-court talc rulings: the moment a docket stops being a filing statistic and starts pricing risk.

Social media: from "untested" to a plaintiff verdict

For three years the social-media docket was a Section 230 argument with no money changing hands. In early 2026 the lead California state-court bellwether broke that pattern: TikTok and Snap settled confidentially before trial, and on March 24 a jury found Meta and Google/YouTube liable for negligently designing platform features that harm adolescent users. The verdict followed a ruling that neither Section 230 nor the First Amendment barred the design-defect theory. The first federal MDL bellwether, a school-district case, is set for June 15, and the Ninth Circuit heard the immunity appeal in January, so an appellate marker could land on top of the trial calendar.

Bard PowerPort: a "defense verdict" that wasn't clean

The first federal PowerPort bellwether went to a jury in Arizona and produced a partial defense verdict: the manufacturer prevailed on failure-to-warn, failure-to-instruct, and consumer-fraud claims, but the jury hung on the central design-defect question. Calling it a defense win overstates it. Additional bellwethers run through early 2027, and the court has pushed the parties into settlement discussions in July.

AFFF: water resolved, personal injury reset

The PFAS story has split cleanly. The public-water track is largely resolved through large settlements with the principal chemical defendants. The personal-injury track, organized around a defined set of qualifying conditions with kidney cancer as the lead, saw its first bellwether pulled off the October calendar and reset, even as the inventory of unfiled claims runs into the tens of thousands.

4. Two structural defenses under pressure

The throughline of 2026 is not any single verdict. It is that two defenses the corporate bar has relied on for years showed cracks in the same window.

Plaintiffs stopped litigating what users posted and started litigating how the product was built. That reframing is what carried a verdict past Section 230.

Section 230. The platform-immunity statute was built for liability over third-party content. The plaintiff bar's move was to stop suing over content and start suing over design: algorithms, notification cadence, infinite scroll, the architecture of engagement. Courts have increasingly let that theory through, and a jury has now accepted it. Immunity is not gone, but the design-defect lane around it is now a proven path rather than a hopeful one.

Bankruptcy. The other shield is the use of Chapter 11 to corral and cap mass-tort liability. J&J's third attempt, the "Texas two-step" via a purpose-built subsidiary, was dismissed, with the court pointing to irregularities in how claimant support was tallied. The proposed multibillion-dollar resolution evaporated, and roughly 90,000 claims returned to active litigation. The lesson for any defendant eyeing the divisional-merger route is that the maneuver is getting harder to land, not easier.

5. What the JPML centralizes, and what it refuses

The Panel's gatekeeping in this cycle rewards two things: a clearly defined injury and a recognizable, bounded set of defendants. Where either is missing, centralization tends to fail. The sharpest illustration came weeks apart, around the same product.

The contrast in the first two rows is the whole lesson. A theory built on a defined harm and a single defendant was centralized; a broader "addiction" theory that would have swept in multiple publishers and an open-ended product universe was refused. The same logic explains the GLP-1 split into two MDLs by injury type, and it is the single best predictor of which emerging theory becomes a docket and which stays a press release.

Ecosystem defendants are now the norm

The defendants in these dockets are rarely a single manufacturer anymore. PFAS names the chemical, formulation, manufacturing, distribution, and successor chain, reaching the principal chemical companies and their corporate descendants. GLP-1 names multiple manufacturers in a drug class while courts separate the claims by injury. Talc has pulled consumer-product allegations into a litigation built on industrial asbestos. The practical drafting implication: defendant identity is a corporate-family question, not a product question.

6. What it means for plaintiff-side practice

Two operational shifts follow from the data. First, Rule 16.1, effective December 1, 2025, formalizes early case management: leadership structure, discovery planning, and early identification of the factual and legal issues. Expect courts and defendants to press sooner for proof of product use, exposure, diagnosis, and injury timing. The documentation burden moves forward in the case, which means intake quality, not intake volume, is where the risk now sits.

Second, the verdict turn changes how a docket should be read. A bellwether outcome is a data point about a single plaintiff, not a verdict on the inventory. The PowerPort result, prevailing on warnings while hanging on design defect, is the textbook example. Treating one bellwether as dispositive, in either direction, is the most common analytical error of the cycle.

The strategic picture for the plaintiff bar is a barbell. At one end, the proven mega-dockets (talc, AFFF, hair relaxer) with known injury definitions and recognizable defendants. At the other, a fast-growing breakout (Depo-Provera) and a coherent new category of platform-harm-to-minors cases (social media, Roblox, rideshare assault) where the law is being made in real time. The thin middle is the speculative theory the JPML has shown it will refuse to centralize.

Sources & method

Case counts are drawn from the JPML's distribution-of-pending-dockets and monthly statistics reports, anchored to the May 1, 2026 report; counts are point-in-time and move monthly. Verdicts, settlements, and procedural milestones are compiled from court records and litigation reporting by Reuters, Law.com/ALM, and established docket trackers. Figures should be re-verified against primary sources before republication. Nothing here is legal advice.